UNICREDIT BANK/CALL/WALGREENS BOOTS ALLIANCE/35/1/15.01.25 Stock

Warrant

DE000HD242G4

Real-time BOERSE MUENCHEN 02:01:08 2024-05-20 am EDT
0.001 EUR -98.95% Intraday chart for UNICREDIT BANK/CALL/WALGREENS BOOTS ALLIANCE/35/1/15.01.25
Current month+3.26%
1 month-26.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-20 0.001 -98.95%
24-05-17 0.095 -13.64%
24-05-16 0.11 +19.57%
24-05-15 0.092 -16.36%
24-05-14 0.11 0.00%

Real-time BOERSE MUENCHEN

Last update May 20, 2024 at 02:01 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying WALGREENS BOOTS ALLIANCE, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD242G
ISINDE000HD242G4
Date issued 2024-01-24
Strike 35 $
Maturity 2025-01-15 (241 Days)
Parity 1 : 1
Emission price 0.75
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.81
Lowest since issue 0.001

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
-
More about the company

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Walgreens Boots Alliance, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
18.18 USD
Average target price
22.77 USD
Spread / Average Target
+25.25%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW